Board and management

Claes Holmberg

Claes Holmberg

Chairman of the Board of Directors of Emotra AB, born 1954

Shareholdings in Emotra AB (including related persons): 1 002 789 shares.

Claes Holmberg has a master’s degree in engineering and received his PhD in theoretical physics in 1986. Former Executive VP of Nobel Biocare, 1986–95 and CEO of Mediteam AB/Biolin AB, 1996–2003 and Biolight AB, 2003–2011. Former member and/or chairman of the board of several medical device companies and national interdisciplinary research programmes.

Daniel Poté

Daniel Poté

President and CEO of Emotra AB, born in 1973

Shareholdings in Emotra AB: 293 992 shares

Daniel Poté has a solid background in international marketing of medical devices. He has previously worked with marketing on a manager level at Nobel Biocare, Haemochrom Diagnostica GmbH and other companies. Mr Poté joined Vitrolife AB in 2009. His area of responsibility there has consistently concerned international marketing activities. In his role as a global product manager at Vitrolife, he has been directly responsible for the majority of that company’s international new product launches.

Lars-Håkan Thorell

Lars-Håkan Thorell

Head of Research and board member of Emotra AB, born 1943

Shareholdings in Emotra AB (including wife’s holdings): 1,290,976 shares.

Lars-Håkan Thorell is the inventor of “EDOR®”, Emotra’s measuring method and product system. Associate professor in experimental psychiatry with more than 40 years’ research experience. He has conducted research on suicide, psychophysiology and hyporeactivity for 25 years. For many of these years his place of employment has been the Institute for Clinical and Experimental Medicine, Psychiatry Department, at the Linköping University.

Anna Sjörs Dahlman

Anna Sjörs Dahlman

Board member of Emotra AB, born 1981

Shareholdings in Emotra AB: 0 shares.

Anna Sjörs Dahlman has a PhD in Rehabilitation Medicine from Linköping University. She has a background in Engineering Biology, with a specialization in non-invasive physiological measurements. The focus in Anna Sjörs Dahlman’s research has been on measuring the biological effects of short and long-term stress exposure, chronic pain, sleep deprivation, physical activity etc. Most of the research has been conducted at the Institute of Stress Medicine in Gothenburg, Sweden.

Dr. Sjörs Dahlman has extensive experience in biomarker research, with an in-depth understanding of the EDOR-Test. She currently holds a position as a researcher at the Swedish national road and transport research institute and as Adjunct Associate Professor at Chalmers University of Technology.

Jan Pilebjer

Jan Pilebjer

Board member of Emotra AB, born in 1954

Shareholdings in Emotra AB: 0 shares.

Jan Pilebjer, born in 1954, who basically holds an economics degree from Uppsala University, is Business Adviser and Business Intelligence Officer at GU Ventures AB. Pilebjer has worked in major worldwide companies and has founded and operated smaller start-up companies in both diagnostics and pharmaceuticals. Among Pilebjer’s international and industrial experiences are companies such as Baxter Healthcare Inc., Nycomed AS, KabiVitrum AB, Medirox AB, Biopool AB and Upjohn AB, where he held his base in countries such as Switzerland, the United States and Denmark.